DEGLYCYRRHIZINATED LICORICE

Oral

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

This monograph is intended to serve as a guide to industry for the preparation of Product Licence Applications (PLAs) and labels for natural health product market authorization. It is not intended to be a comprehensive review of the medicinal ingredient.

Notes

Date

October 30, 2018

Proper name(s), Common name(s), Source material(s)

Table 1. Proper name(s), Common name(s), Source material(s)
Proper name(s) Common name(s)
Source material(s)
Proper name(s) Part(s)

Deglycyrrhizinated licorice

  • Deglycyrrhizinated licorice
  • DGL
  • Glycyrrhiza glabra
  • Glycyrrhiza inflata
  • Glycyrrhiza uralensis
  • Root
  • Root and stolon
  • Root and rhizome
  • Root, rhizome and stolon

References: Proper name: NHPID 2018; Common names: Pizzorno and Murray 2006, Blumenthal et al. 2000; Source materials: USDA 2018, USP 32 2009, BP 2008, Ph. Eur. 2008.

Route of Administration

Oral

Dosage Form(s)

This monograph excludes foods or food-like dosage forms as indicated in the Compendium of Monographs Guidance Document.

Acceptable dosage forms for the age category listed in this monograph and specified route of administration are limited to chewables.

Use(s) or Purpose(s)

The following combined use(s) or purpose(s) is/are also acceptable:

Dose(s)

Subpopulation(s)

As listed below.

Quantity(ies)

Method of preparation: Dry extract

Table 2. Dose information for Deglycyrrhizinated licorice extract (chewable dosage forms only)

Subpopulation(s)

Deglycyrrhizinated licorice extract (milligram)
Minimum/single dose Maximum/single dose
Frequency
Minimum
Maximum

Children 1

3-4 years

63 mg

253 mg

3

3

5-9 years

95 mg

380 mg

3

3

10-11 years

190 mg

760 mg

3

3

Adolescents 1

12-14 years

190 mg

760 mg

3

3

15-17 years

380 mg

1520 mg

3

3

Adults 2

18 years and older

380 mg

1520 mg

3

3

Table 2 Footnotes

Table 2 Footnote 1

Children and adolescent doses were calculated as a fraction of the adult dose (JC 2018). The use of licorice in children and adolescents is supported by the following references: McIntyre 2005; Schilcher 1997; Bove 1996.

Return to Table 2 footnote1 referrer

Table 2 Footnote 2

Adult doses are supported by Pizzorno and Murray 2006.

Return to Table 2 footnote2 referrer

Direction(s) for use

Chew between meals or 20 minutes before meals, 3 times a day (Pizzorno and Murray 2006).

Duration(s) of Use

No statement required.

Risk Information

Caution(s) and warning(s)

Consult a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

Contraindication(s)

No statement required.

Known adverse reaction(s)

No statement required.

Non-medicinal ingredients

Must be chosen from the current Natural Health Products Ingredients Database (NHPID) and must meet the limitations outlined in the database.

Storage conditions

No statement required.

Specifications

References Cited

References Reviewed